Cargando…

Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities

Physiologically based pharmacokinetic (PBPK) modeling is an approach to predicting drug pharmacokinetics, using knowledge of the human physiology involved and drug physiochemical properties. This approach is useful when predicting drug pharmacokinetics in under-studied populations, such as pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dinh, Jean, Johnson, Trevor N., Grimstein, Manuela, Lewis, Tamorah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675397/ https://www.ncbi.nlm.nih.gov/pubmed/38004559 http://dx.doi.org/10.3390/pharmaceutics15112579

Ejemplares similares

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making
por: Reig-López, Javier, et al.
Publicado: (2021)

Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life
por: Krzyzanski, Wojciech, et al.
Publicado: (2022)

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development
por: Zhao, Sherry, et al.
Publicado: (2021)

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018)

Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations
por: Ke, Alice Ban, et al.
Publicado: (2018)

Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
por: Lewis, Tamorah, et al.
Publicado: (2021)

Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
por: Sedighi, Mansour, et al.
Publicado: (2019)

Nanobiotechnology to advance stress resilience in plants: Current opportunities and challenges
por: Ijaz, Munazza, et al.
Publicado: (2023)

Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population
por: O’Hara, Kate, et al.
Publicado: (2020)

Antibiotic stewardship in neonates: challenges and opportunities
por: Ting, Joseph Y., et al.
Publicado: (2020)

Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates
por: Matcha, Saikumar, et al.
Publicado: (2023)

Editorial: In Vitro models: opportunities and challenges in aquatic physiology
por: Moyano, Francisco Javier, et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis – challenges and opportunities
por: Van Bocxlaer, Katrien, et al.
Publicado: (2021)

Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
por: De Sutter, Pieter-Jan, et al.
Publicado: (2023)

Weighing trees with lasers: advances, challenges and opportunities
por: Disney, M. I., et al.
Publicado: (2018)

Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children
por: Zhou, W, et al.
Publicado: (2016)

A regulatory science viewpoint on botanical–drug interactions
por: Grimstein, Manuela, et al.
Publicado: (2018)

Role of Physiological Resilience in Aging: Challenges and Opportunities
por: Huffman, Derek
Publicado: (2021)

Early-Onset Neonatal Sepsis in Low- and Middle-Income Countries: Current Challenges and Future Opportunities
por: Sands, Kirsty, et al.
Publicado: (2022)

Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants
por: Gibiansky, Leonid, et al.
Publicado: (2020)

Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
por: Kovar, Lukas, et al.
Publicado: (2020)

Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations
por: Johnson, Trevor N., et al.
Publicado: (2022)

Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities
por: Lewis, David John, et al.
Publicado: (2019)

Diabetic Complications: Current Challenges and Opportunities
por: Nickerson, Helen D., et al.
Publicado: (2012)

Metallic Biomaterials: Current Challenges and Opportunities
por: Prasad, Karthika, et al.
Publicado: (2017)

Current Challenges and Opportunities in Treating Glioblastoma
por: Shergalis, Andrea, et al.
Publicado: (2018)

Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2015)

Cardiac Optogenetics in Atrial Fibrillation: Current Challenges and Future Opportunities
por: Floria, Mariana, et al.
Publicado: (2020)

Physiologically‐Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug–Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations
por: Taskar, Kunal S., et al.
Publicado: (2019)

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
por: Lommerse, Jos, et al.
Publicado: (2019)

Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
por: Utembe, Wells, et al.
Publicado: (2020)

Assessment of the Utility of Physiologically-based Pharmacokinetic Model for prediction of Pharmacokinetics in Chinese and Japanese Populations
por: Yu, Yanke, et al.
Publicado: (2021)

Editorial: Invertebrates as model organisms: opportunities and challenges in physiology and bioscience research
por: Krishnan, Natraj, et al.
Publicado: (2023)

Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK
por: Zazo, Hinojal, et al.
Publicado: (2022)

A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities
por: Serper, Marina, et al.
Publicado: (2020)

Advances in Nutrition: Opportunities and Challenges in 2022
por: Pérez-Cano, Francisco J.
Publicado: (2023)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Editorial: Model organisms and experimental models: opportunities and challenges in clinical and translational physiology
por: Myslivecek, Jaromir, et al.
Publicado: (2023)

Editorial: Model organisms and experimental models: opportunities and challenges in vascular physiology research
por: Pulgar, Victor M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hciupr4p3lkcp1a6g51jalqd6i